Zhitong Finance App News, Shanghai Pharmaceutical (601607.SH) announced that the company plans to participate in the establishment of the Shanghai Shangshi Biomedical Industry Private Equity Fund Partnership (Limited Partnership) as one of the limited partners, with a proposed capital of 300 million yuan. The target fundraising scale of the fund is 2 billion yuan.

Zhitong Finance App News, Shanghai Pharmaceutical (601607.SH) announced that the company plans to participate in the establishment of the Shanghai Shangshi Biomedical Industry Private Equity Fund Partnership (Limited Partnership) as one of the limited partners, with a proposed capital of 300 million yuan. The target fundraising scale of the fund is 2 billion yuan.